近日，总投资超千万元的尚九鲜海参加工项目，签约落地城厢区灵川镇。"项目与此前企业在灵川设立 的北参南养基地，将形成海参养殖、加工、销售产业链闭环。"尚九鲜副董事长王晨对未来充满了憧 憬。 立春时节，在灵川镇书峰村与西墩村交界处的海面上，绵延相连的网箱错落有致，养殖人员边投掷饵料 边观察海参长势，"海上春耕"忙碌。这里便是尚九鲜的北参南养基地。 回忆起基地落地之初，王晨至今记忆犹新。"当初最头疼的是选址和清障，多亏了片区党委的统筹协 调。"王晨介绍，为让项目顺利推进，灵川镇"有渔粮"片区牵头对接海渔部门开展勘测，选定避开主航 道、水质佳的养殖海域，并组织清理海域内零散非法养殖设施，确保项目赶在海参冬眠前投产。去年， 基地首批400余万斤海参喜获丰收。 据悉，此次落地的尚九鲜海参加工项目，将进一步延伸产业链，开发即食海参、预制菜等产品，让海参 实现价值跃升。 地处湄洲湾畔的灵川镇坐拥13公里黄金海岸线，海域平缓、气候适宜，却曾因村域分割、资源分散，陷 入"守着宝地难致富"困境。去年3月，"有渔粮"片区党委应势成立，串联起东进、下尾、书峰、西墩4个 沿海村庄，通过组织联建，统筹海域、资金、人才等要素，让分散的资源聚 ...

邱处机 . 专门研究商业牛人 豪赌新能源时代。 以下文章来源于邱处机 ，作者邱鑫浩 作者：邱鑫浩 来源：邱处机 河南栾川县的崇山峻岭间，洛阳钼业的三道庄矿区里，无人挖矿机正在有条不紊地作业，数十 辆无人驾驶矿卡在蜿蜒的矿道上川流不息。 这家全球最大的钴生产商、全球十大铜生产商、巴西领先的磷肥生产商，已成为中国矿企国际 化的典范，市值接近 5000 亿元。 作为洛阳钼业的实控人，于泳在胡润富豪榜最新数据里的身家高达 950 亿。 但有意思的是，这位矿产大佬是一位几乎不在公开场合露面的神秘富豪。他从不担任公司任何 职务，甚至缺席了公司两次上市仪式。 这里插播一条课程资讯： 报名 「 黑马·欧洲游学 」， 7天6晚， 我们将带您 回到品牌的"第一现场"， 从 巴黎到米兰 ，直击 LV、欧莱雅、Prada 等顶流品牌的诞生地与核心工厂。 我们还将潜入IFM学院解密奢侈品管理逻辑，在蓝带学院领悟生活方式定义权，更能探访Loro Piana面料实验室，解锁产业链密码。 30席限量抢位， 带你用欧洲思维重构品牌壁垒，从"卖产品"到"卖梦想"，用文化重新定义品 牌定价权！ 扫码咨询报名 （翻到底部了解详情） 01 捡 漏 于 ...

Core Viewpoint - Daon Co., Ltd. is actively pursuing globalization through strategic acquisitions, enhancing its position in the polymer composite materials industry, particularly in Southeast Asia [2][3]. Group 1: Acquisition Details - Daon Co., Ltd. announced plans to acquire a plastic compound business unit in Vietnam for approximately $1.5737 million (about 109 million RMB), marking a significant step in its global expansion strategy [2]. - The target business, part of Hwaseung Chemical Vietnam Co., Ltd., reported revenue of $1.2576 million and a net profit of $449,000 for the first half of 2025, indicating solid profitability [2]. - This acquisition follows a previous announcement to acquire 80% of Ningbo Aisikai Synthetic Rubber Co., Ltd. for 516 million RMB, with a total transaction value of approximately 581 million RMB [3]. Group 2: Strategic Importance - The acquisition is aimed at localizing production in response to key customers shifting their supply chains to Southeast Asia, which will help reduce logistics costs and improve delivery times [3]. - Daon Co., Ltd. emphasizes that this move is crucial for strengthening customer relationships and enhancing order acquisition capabilities [3]. Group 3: Market Position and Innovation - Daon Co., Ltd. is recognized as a leading player in the domestic rubber and plastic industry, focusing on thermoplastic elastomers (TPV) and modified plastics [8]. - The company has developed a high-end tire barrier material, DVA, which has significant commercial potential and is expected to capture a substantial market share in the tire industry [7]. - DVA's market potential is estimated to generate 2.4 billion RMB in revenue if it achieves a 10% penetration rate in China's annual tire production of 1.2 billion units [7].

Core Viewpoint - The Tangshan Haigang Economic Development Zone has initiated trial production of the Bino Phase II medium and thick plate shipbuilding processing project, addressing a gap in regional ship plate manufacturing [1] Investment and Project Details - The total investment for the Bino Phase II project is 550 million yuan, which includes the establishment of fully automated steel pre-treatment production lines, shot blasting production lines, and painting equipment [1] - The project employs advanced international shot blasting and painting technologies for specialized surface treatment, significantly enhancing product surface quality and lifespan [1] - The designed annual production capacity is 500,000 tons, with projected annual revenue exceeding 2 billion yuan upon reaching full capacity [1] Government Support and Operational Efficiency - The Haigang District has implemented measures to optimize approval processes and strengthen resource supply guarantees, facilitating efficient project advancement [1] - The project utilizes a "stock acquisition" model to revitalize 147 acres of idle land and associated facilities, eliminating the need for new land acquisition processes [1] - The project leverages its geographical advantage by being adjacent to Jingye Huaxi Special Steel and Tangshan Medium and Thick Plate Company, creating a closed-loop industrial chain of "local steel - local processing - local settlement" [1] Cost Efficiency and Market Integration - The initiative aims to reduce logistics costs and enhance the steel supply rate, supporting "Haigang manufacturing" in connecting with both domestic and international high-end shipbuilding markets [1]

Core Insights - The local frozen "green oil beans" from Tongjiang have successfully been exported to Khabarovsk, Russia, marking the establishment of a complete industrial chain from planting to processing and export, transitioning from a "channel economy" to a "landed economy" with higher added value and stronger driving force [1] Group 1 - The frozen "green oil beans" are produced by Tongjiang Jingdu Cold Chain Logistics Co., Ltd., which operates a 450-acre planting base [5] - The company employs "water and fertilizer integration + large ridge double-row" technology to ensure quality from the source, with beans being frozen immediately after harvesting [5] - The export process is facilitated by the floating box solid ice channel, which allows for rapid export through the Tongjiang port, creating a closed-loop industrial chain [5] Group 2 - The transportation of goods has been made easier by the floating box solid ice channel, with Russian drivers noting the convenience of travel between Russia and China [2] - The local port authorities have optimized regulatory services by implementing measures such as "advance declaration and appointment inspection," significantly reducing customs clearance time [5] - These improvements enable local agricultural products to achieve "zero delay" in customs clearance and increased export speed [5]

Core Viewpoint - The transfer of control and asset injection into Rhine Biotech is seen as a crucial move to address the company's operational challenges and enhance its market position following the departure of its founder due to regulatory penalties [1][2]. Group 1: Control Change and Asset Injection - Rhine Biotech's controlling shareholder, Qin Benjun, plans to transfer 8.09% of shares to Guangzhou Defu Nutrition for 645.6 million yuan, relinquishing 25.5% of voting rights [1][3]. - After the transfer, Guangzhou Defu Nutrition will become the controlling shareholder, with Hou Ming and Li Zhenfu as joint actual controllers [1][3]. - The company will also acquire an 80% stake in Beijing Jinkangpu Food Technology through a share issuance, marking a significant asset injection [1][5]. Group 2: Financial Performance and Challenges - For the first three quarters of 2025, Rhine Biotech reported revenues of 1.272 billion yuan, an increase of 8.73%, but a net profit of 70.4 million yuan, down 30.73% year-on-year [1][8]. - Qin Benjun faces significant financial pressure, with over 65% of his shares pledged and a financing balance of 207 million yuan due within six months [1][8]. Group 3: New Business Direction - The acquisition of Beijing Jinkangpu, a leader in food nutrition fortifiers, allows Rhine Biotech to enter the nutrition health sector, expanding its business model [7][10]. - Beijing Jinkangpu's revenue for 2023 to the first nine months of 2025 was 370 million yuan, 432 million yuan, and 338 million yuan, respectively [9]. - The transaction is expected to create a closed-loop industry chain from raw materials to formulation solutions, enhancing operational stability and risk resilience for Rhine Biotech [10]. Group 4: Market Reaction - Following the announcement of the control change and restructuring plan, Rhine Biotech's stock price hit the daily limit, closing at 9.57 yuan per share, a 10% increase [11].

Core Viewpoint - Rhine Biotech (002166) has officially disclosed its asset restructuring and control change plan after a 10-day trading suspension, intending to issue shares to Guangzhou Defu Nutrition Investment Partnership and change its controlling shareholder to Guangzhou Defu Nutrition [1][2] Group 1: Share Transfer and Control Change - The control change framework agreement was signed on December 22, where Qin Benjun, the controlling shareholder, will transfer 8.09% of shares to Guangzhou Defu Nutrition and relinquish 25.50% of voting rights while retaining 3% [2] - After the transaction, Guangzhou Defu Nutrition will hold 8.09% of shares and 11.17% of voting rights, while Qin Benjun will retain 28.50% of shares and 4.14% of voting rights [2] - The total transaction price is estimated at 646 million yuan, with a transfer price of 10.76 yuan per share, representing a premium of 23.68% compared to the closing price of 8.70 yuan before the suspension [2] Group 2: Strategic Intent and Business Expansion - Guangzhou Defu Nutrition, established on December 2, 2025, is an investment company focused on the healthcare sector, managing nearly 24 billion yuan in healthcare assets [3] - Rhine Biotech aims to leverage Defu Capital's resources to enhance its investment and acquisition capabilities in the healthcare sector, creating a comprehensive health ecosystem [3] - The company has signed agreements to acquire 80% of Beijing Jinkangpu, a leading enterprise in the field of nutritional fortifiers, thereby expanding its business into the nutritional fortifier formulation sector [4][6] Group 3: Financial Performance of Beijing Jinkangpu - As of September 2023, Beijing Jinkangpu reported total assets of 593 million yuan and net assets of 535 million yuan, with revenues of 338 million yuan and a net profit of 40.33 million yuan for the first three quarters of 2025 [4]

Core Viewpoint - The stock of Rhine Biotech (002166.SZ) resumed trading and hit the daily limit, closing at 9.57 yuan, a 10.00% increase, following the announcement of a change in control and related agreements [1]. Group 1: Control Change Agreements - The controlling shareholder Qin Benjun signed several agreements with Guangzhou Defu Nutrition Investment Partnership, including a framework agreement for control change and a share transfer agreement, transferring 60 million shares (8.09% of total shares) and relinquishing voting rights for 189,141,310 shares (25.50% of total shares) [2][8]. - After the transfer, Guangzhou Defu Nutrition will become the controlling shareholder, with Hou Ming and Li Zhenfu as the joint actual controllers of the company [4][8]. Group 2: Share Transfer Details - The share transfer price was set at 10.76 yuan per share, totaling 645.6 million yuan, inclusive of all applicable taxes [3]. - Post-transfer, Qin Benjun will retain voting rights for 22,248,282 shares (3.00% of total shares) [2][8]. Group 3: Asset Purchase and Fundraising - The company plans to issue shares to acquire 80% of Beijing Jinkangpu's equity from Defu Jinkangpu and Xiamen Defu Jinkangpu, and to raise funds for purchasing additional shares from individual shareholders [4][6]. - The final transaction price for the assets will be based on an evaluation report from a qualified asset appraisal agency [5]. - The company aims to expand its business into the nutritional fortifier sector, enhancing its operational stability and risk resistance [6][7]. Group 4: Financial Performance of Target Company - For the fiscal year 2024 and the first three quarters of 2025, Beijing Jinkangpu reported revenues of 431.82 million yuan and 337.65 million yuan, respectively, with net profits of 70.27 million yuan and 40.33 million yuan, and a return on equity of 14.33% and 7.60% [7].

Group 1 - The company announced a control change agreement where Qin Benjun will transfer 60 million shares (8.09%) to Guangzhou Defu Nutrition and relinquish voting rights for 189,141,310 shares (25.50%), retaining voting rights for 22,248,282 shares (3.00%) [1] - Following the completion of the share transfer and board restructuring, Guangzhou Defu Nutrition will become the controlling shareholder, with Hou Ming and Li Zhenfu as the joint actual controllers [1] - The company plans to acquire 80% of Beijing Jinkangpu Food Technology Co., Ltd. through a share issuance to Defu Jinkangpu Holdings and Xiamen Defu Jinkangpu Investment [1] Group 2 - The target company specializes in the formulation, production, testing, sales, and technical services of food nutrition fortifiers, serving various sectors including dairy products and health foods [2] - The target company is a leading enterprise in the food nutrition fortifier industry, supplying to numerous infant formula manufacturers [2] - The acquisition will enhance the company's business structure, creating a closed-loop industry chain from raw materials to formulation solutions, thereby improving operational stability and risk resistance [2] Group 3 - The company's stock will resume trading on December 24, 2025 [3]

Group 1 - The company announced a change in control agreement where Qin Benjun will transfer 60 million shares (8.09%) to Guangzhou Defu Nutrition and relinquish voting rights for 189,141,310 shares (25.50%), retaining voting rights for 22,248,282 shares (3.00%) [1] - Following the completion of the share transfer and board restructuring, Guangzhou Defu Nutrition will become the controlling shareholder, with Hou Ming and Li Zhenfu as the joint actual controllers of the company [1] - The company plans to acquire 80% of Beijing Jinkangpu Food Technology Co., Ltd. through a share issuance to Defu Jinkangpu Holdings and Xiamen Defu Jinkangpu Investment [1] Group 2 - The target company specializes in the formulation, production, testing, sales, and technical services of food nutrition fortifiers, serving various sectors including dairy products and functional beverages [2] - The target company is a leading enterprise in the food nutrition fortifier industry, supplying to numerous infant formula manufacturers [2] - The acquisition will enhance the company's business structure, making it more diversified and improving operational stability and risk resistance [2] Group 3 - The company's stock will resume trading on December 24, 2025 [3]